Findings
The lack of standardization in vendor onboarding processes increases operational inefficiencies for sponsors and vendors.
Essential topics such as data security, quality management systems (QMS), and validation studies are under-addressed in ad hoc vendor assessments.
Cybersecurity and patient data privacy, especially compliance with GDPR, HIPAA, and global regulations, require enhanced focus during vendor evaluations.
Tailoring vendor assessments to specific trial requirements and patient populations is critical for effective implementation of digital health tools.
Greater collaboration between sponsors and vendors can improve operational alignment and mitigate risks during trials.

Recommendations
Utilize the 13 vendor assessment categories as a baseline for customizing questionnaires to meet specific project needs.
Establish standardized templates for evaluating data privacy, regulatory compliance, and patient-facing user experience.
Prioritize cybersecurity measures, including penetration testing, access management, and encryption standards, as a core assessment criterion.
Implement continuous feedback loops during vendor selection and onboarding to refine assessment processes and address emerging risks.
Encourage industry collaboration to evolve and expand the open-source framework based on practical implementation experiences.

Regulatory Considerations
Ensure all vendors adhere to relevant global standards, including 21 CFR Part 11, GDPR, and HIPAA, for data security and compliance.
Verify the regulatory status of medical devices and algorithms used in digital health solutions, including certifications such as ISO 13485 and IEC 62304.
Require documentation of informed consent processes and adherence to regional data protection regulations for patient data handling.
Align vendor capabilities with regulatory guidelines for clinical trial endpoints, emphasizing validation studies and clinical relevance.
Maintain transparent and audit-ready documentation for inspections and compliance verifications.